title: Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?
authors.affiliation: Gertrude H Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. lk24@coloumbia.edu
authors.forename: Louise
authors.initials: L
authors.lastname: Kuhn
authors.forename: Ida
authors.initials: I
authors.lastname: Susser
authors.forename: Zena
authors.initials: Z
authors.lastname: Stein
mesh_terms: D000282:Administration, Intravaginal; D000284:Administration, Oral; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission*; D020010:Heterosexuality; D006801:Humans; D008297:Male; D055118:Medication Adherence; D016032:Randomized Controlled Trials as Topic / Q000592:standards / Q000639:trends; D012309:Risk-Taking; D012725:Sexual Behavior; D013019:South Africa / Q000453:epidemiology
chemical_list: D044966:Anti-Retroviral Agents